Sign up to save your podcasts
Or
Share E126: Risk Signals, JAKs, and SELECTIVE-ity
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
E126: Risk Signals, JAKs, and SELECTIVE-ity
Covering an interesting but ultimately disappointing post hoc study of multiple upadacitinib trials in RA. Initially some hope for clarity in the "Do JAKs cause all the badness?" questions, but ultimately landing me about where I have been since ORAL-SURVEILLANCE was published
Paper: https://www.sciencedirect.com/science/article/pii/S0003496724423091
View all episodes
By Michael Putman
4.9
114114 ratings
Covering an interesting but ultimately disappointing post hoc study of multiple upadacitinib trials in RA. Initially some hope for clarity in the "Do JAKs cause all the badness?" questions, but ultimately landing me about where I have been since ORAL-SURVEILLANCE was published
Paper: https://www.sciencedirect.com/science/article/pii/S0003496724423091
More shows like The Evidence Based Rheumatology Podcast
View all
JAMA Clinical Reviews
502 Listeners
Mayo Clinic Talks
300 Listeners
Rheumnow Podcast
124 Listeners
The Curbsiders Internal Medicine Podcast
3,383 Listeners
Core IM | Internal Medicine Podcast
1,151 Listeners
Healio Rheuminations
121 Listeners
Annals On Call Podcast
196 Listeners
The Clinical Problem Solvers
517 Listeners
ACR on Air
66 Listeners
Around the Rheum with Drs. Daniel Ennis & Janet Pope
5 Listeners
The Curious Clinicians
378 Listeners
Rheumatology For The Royal College
184 Listeners
Febrile
188 Listeners
ACR Journals On Air
20 Listeners
Talking Rheumatology Spotlight
6 Listeners